{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:46:24Z","timestamp":1790696784569,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006306.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000}}],"reference-count":95,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006306.pub3","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T12:08:03Z","timestamp":1458389283000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antipsychotic medications for cocaine dependence"],"prefix":"10.1002","volume":"2016","author":[{"given":"Blanca I","family":"Indave","sequence":"first","affiliation":[{"name":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pani","sequence":"additional","affiliation":[{"name":"Health District 8 (ASL 8) Cagliari; Social-Health Division; Via Romagna 17 Cagliari Sardinia Italy 09128"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/10550490701389658","article-title":"Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia","volume":"16","author":"Akerele","year":"2007","journal-title":"The American Journal on Addictions"},{"issue":"S1","key":"10.1002\/14651858.CD006306.pub3-BIB0002|cit2","first-page":"25","article-title":"A randomized, double-blind, placebo-controlled pilot study of quetiapine in outpatients with bipolar disorder and cocaine dependence","volume":"11","author":"Brown","year":"2009","journal-title":"Bipolar Disorders"},{"issue":"11","key":"10.1002\/14651858.CD006306.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2012.90","article-title":"A randomized, double-blind, placebo-controlled trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence","volume":"37","author":"Brown","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD006306.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10550490802544318","article-title":"Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial","volume":"18","author":"Hamilton","year":"2009","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/105504999305929","article-title":"Pergolide mesylate for cocaine abuse: a controlled preliminary trial","volume":"8","author":"Levin","year":"1999","journal-title":"The American Journal on Addiction"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4088\/JCP.v69n0321","article-title":"A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men","volume":"69","author":"Loebl","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"14","key":"10.1002\/14651858.CD006306.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/138161211796150783","article-title":"Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study","volume":"17","author":"Meini","year":"2011","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0010|cit10","first-page":"179","article-title":"Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study","volume":"20","author":"Meini","year":"2010","journal-title":"The American Journal on Addictions"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006306.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2004.03.009","article-title":"A double-blind placebo controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients","volume":"27","author":"Smelson","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.jcp.0000194624.07611.5e","article-title":"The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence","volume":"26","author":"Smelson","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0014|cit14","unstructured":"NCT00631748 Quetiapine for the reduction of cocaine use clinicaltrials.gov\/ct2\/show\/results\/NCT00631748 2014"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0015|cit15","first-page":"2733","article-title":"Quetiapine for the treatment of cocaine dependence","volume":"38","author":"Tapp","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"S1","key":"10.1002\/14651858.CD006306.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0924-9338(13)77333-4","article-title":"Quetiapine for the treatment of cocaine dependence","volume":"28","author":"Tapp","year":"2013","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"18\u201324","DOI":"10.1016\/j.drugalcdep.2014.12.037","article-title":"Quetiapine for the treatment of cocaine use disorder","volume":"149","author":"Tapp","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2-3","key":"10.1002\/14651858.CD006306.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2007.05.021","article-title":"A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence","volume":"91","author":"Winhusen","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"9000","key":"10.1002\/14651858.CD006306.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(96)91139-3","article-title":"Haloperidol antagonism of cue-elicited cocaine craving","volume":"347","author":"Berger","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archgenpsychiatry.2010.60","article-title":"Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence","volume":"67","author":"Ersche","year":"2010","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(01)00129-6","article-title":"Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans","volume":"64","author":"Evans","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(99)00114-3","article-title":"Significant interaction between clozapine and cocaine in cocaine addicts","volume":"59","author":"Farren","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","article-title":"Risperidone for the treatment of cocaine dependence: randomized, double trial","volume":"20","author":"Grabowski","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0024|cit24","unstructured":"NCT00218036 Pharmacotherapy dosing regimen in cocaine and opiate dependent individuals clinicaltrials.gov\/ct2\/show\/record\/NCT00218036"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","article-title":"Aripiprazole maintenance increases smoked cocaine self-administration in humans","volume":"216","author":"Haney","year":"2011","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006306.pub3-BIB0026|cit26","first-page":"160","article-title":"Olanzapina and cocaine consumption in methadone maintenance programs: new results","volume":"10","author":"Landabaso","year":"2003","journal-title":"Psiquiatr\u00eda Biol\u00f3gica"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0027|cit27","first-page":"21","article-title":"Clinical trial on the use of olanzapine in reducing the consumption of cocaine in methadone maintenance programmes","volume":"11","author":"Vazquez","year":"2009","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00952990802308262","article-title":"The safety, tolerability and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: Increased aripipirazole dose and maintenance period","volume":"34","author":"Lile","year":"2008","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"11","key":"10.1002\/14651858.CD006306.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1177\/0269881110385597","article-title":"Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans","volume":"25","author":"Lile","year":"2011","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/a0035165","article-title":"Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans","volume":"22","author":"Lofwall","year":"2014","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0031|cit31","first-page":"138","article-title":"Treatment with amisulpride of addicted patients to psychoactive substances and psychotic symptoms","volume":"38","author":"M\u00e1\u00f1ez","year":"2010","journal-title":"Actas Espa\u00f1olas de Psiquiatr\u00eda"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0032|cit32","unstructured":"Middleton L Lofwall M Nuzzo PA Walsh SL Safety of oral aripiprazole alone and in combination with intravenous cocaine in humans Proceedings of the 71st Annual Scientific Meeting of the College on Problems of Drug Dependence; Reno\/Sparks, Nevada, USA 2009 102"},{"issue":"8","key":"10.1002\/14651858.CD006306.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4088\/JCP.v69n0808","article-title":"Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial","volume":"69","author":"Nejtek","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0034|cit34","unstructured":"Nuzzo PA Lofwall MR Walsh SL Aripiprazole effects on cigarette smoking among cocaine users Proceedings of the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, Palm Springs, CA , Abstract 2012"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0035|cit35","unstructured":"Price LH Pelton GH McDougle CJ Malison RT Jatlow P Carpenter L Effects of acute pretreatment with risperidone on responses to cocaine in cocaine addicts Poster presented at the 36th Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, Hawai, USA 1997"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4321\/S0213-61632006000300001","article-title":"Risperidone versus zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity: a long-term randomized, controlled, crossover study","volume":"20","author":"Rubio","year":"2006","journal-title":"The European Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD006306.pub3-BIB0037|cit37","first-page":"531","article-title":"Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity","volume":"51","author":"Rubio","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0038|cit38","first-page":"326","article-title":"Aripiprazole as a pharmacotherapy for cocaine dependence","volume":"18","author":"Rush","year":"2009","journal-title":"The American Journal on Addiction"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.nmd.0000165089.14736.bf","article-title":"Cocaine abuse in schizophrenic patients with olanzapine versus haloperidol","volume":"139","author":"Sayers","year":"2005","journal-title":"The Journal of Nervous and Mental Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-1781(89)90127-3","article-title":"Effects of intravenous cocaine are partially attenuated by haloperidol","volume":"27","author":"Sherer","year":"1988","journal-title":"Psychiatry Research"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/00952990701651556","article-title":"The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance","volume":"33","author":"Stoops","year":"2007","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"12","key":"10.1002\/14651858.CD006306.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4088\/JCP.v63n1214c","article-title":"Olanzapine treatment for patients with schizophrenia and cocaine abuse","volume":"63","author":"Tsuang","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005063.pub3","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0044|cit44","volume-title":"Beck Depression Inventory, 2nd edn","author":"Beck","year":"1996"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004850-199905030-00005","article-title":"A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double blind, randomized controlled trial","volume":"14","author":"Berk","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007380.pub3","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","author":"Castells","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00001504-200205000-00006","article-title":"Cocaine dependence: the challenge for pharmacotherapy","volume":"15","author":"Dackis","year":"2002","journal-title":"Current Opinion in Psychiatry"},{"issue":"14","key":"10.1002\/14651858.CD006306.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Chiara","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0893-133X(99)00079-2","article-title":"PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum","volume":"21","author":"Drevets","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0051|cit51","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"1994"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0052|cit52","unstructured":"European Monitoring Centre for Drug and Drug Addiction Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries. www.emcdda.europa.eu\/attachements.cfm\/att_226037_EN_Cocaine_emergencies_report_final.pdf"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0053|cit53","unstructured":"European Monitoring Centre for Drugs and Drug Addiction Data and statistics by topic www.emcdda.europa.eu\/data\/2014"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0054|cit54","unstructured":"European Monitoring Centre for Drugs and Drug Addiction European Drug Report 2015: Trends and developments www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2015 2015"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0056|cit56","first-page":"685","article-title":"The serotonergic system and its role in cocaine addiction","volume":"57","author":"Filip","year":"2005","journal-title":"Pharmacological Reports"},{"issue":"6","key":"10.1002\/14651858.CD006306.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence","volume":"17","author":"Grabowski","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7454","key":"10.1002\/14651858.CD006306.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0059|cit59","volume-title":"Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"7650","key":"10.1002\/14651858.CD006306.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0010-440X(91)90066-L","article-title":"The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale","volume":"32","author":"Halikas","year":"1991","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"The British Journal Medical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"British Journal ofSocial and Clinical Psychology"},{"issue":"7","key":"10.1002\/14651858.CD006306.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0066|cit66","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4603(98)00011-2","article-title":"Reliability and validity of the cocaine selective severity assessment","volume":"23","author":"Kampman","year":"1998","journal-title":"Addictive Behavaviors"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0068|cit68","volume-title":"A Brief History of Cocaine","volume":"2nd edition","author":"Karch","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0069|cit69","first-page":"58","article-title":"A review of pharmacotherapies for substance abuse","volume":"5","author":"Kosten","year":"1996","journal-title":"American Journal of Addiction"},{"issue":"7","key":"10.1002\/14651858.CD006306.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0165-6147(96)10024-9","article-title":"Neurochemical changes in cocaine withdrawal","volume":"17","author":"Kuhar","year":"1996","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomised controlled trials","volume":"35","author":"Leucht","year":"1999","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002023.pub2","article-title":"Carbamazepine for cocaine dependence","author":"Lima Reisser","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006306.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006306.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1017\/S0033291700009934","article-title":"Clinical applications of visual analogue scales. A critical review","volume":"18","author":"McCormack","year":"1988","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal of Substance Abuse and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005064.pub3","article-title":"Anticonvulsants for alcohol withdrawal","author":"Minozzi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006306.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003352.pub4","article-title":"Dopamine agonists for the treatment of cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0078|cit78","first-page":"781","article-title":"Abnormal Involuntary Movement Scale (AIMS)","volume":"24","author":"National Institute of Mental Health (NIMH)","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0079|cit79","unstructured":"Substance Abuse and Mental Health Services Administration The NSDUH Report: substance use and mental health estimates from the 2013 National Survey on drug use and health: overview of findings Summary of national findings (HHS Publication No. 14\u20134863, NSDUH Series H\u201348). Rockville MD"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0080|cit80","first-page":"621","article-title":"Drug addiction and drug abuse","volume-title":"The Pharmacological Basis of Therapeutics","author":"O'Brian","year":"2001"},{"issue":"12","key":"10.1002\/14651858.CD006306.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002950.pub3","article-title":"Antidepressants for cocaine dependence and problematic cocaine use","author":"Pani","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006306.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"573\u201383","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006306.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1097-4679(199901)55:1<135::AID-JCLP14>3.0.CO;2-8","article-title":"Initial validation of the Voris cocaine craving scale: a preliminary report","volume":"55","author":"Smelson","year":"1999","journal-title":"Journal of Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale","volume":"167","author":"Snaith","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"41\u201372","DOI":"10.1007\/978-1-4612-0357-5_3","article-title":"Timeline follow-back: a technique for assessing self-reported alcohol consumption","volume-title":"Measuring Alcohol Consumption","author":"Sobell","year":"1992"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0088|cit88","unstructured":"Somoza E Dyrenforth S Goldsmith J Mezinskis J Cohen M In search of a universal drug craving scale Annual Meeting of the American Psychiatric Association 1995"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0089|cit89","volume-title":"Preventing AIDS in Drug Abusers and their Sexual Partners","author":"Sorensen","year":"1991"},{"issue":"1","key":"10.1002\/14651858.CD006306.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0376-8716(93)90042-O","article-title":"The development of a cocaine craving questionnaire","volume":"34","author":"Tiffany","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0091|cit91","unstructured":"United Nations Office on Drugs and Crime World Drug Report 2015 www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf"},{"issue":"10","key":"10.1002\/14651858.CD006306.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: Insights for imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1002\/14651858.CD006306.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archpsyc.1990.01810210069010","article-title":"Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study","volume":"47","author":"Weddington","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006306.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"429\u201335","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006306.pub3-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006306.pub2","article-title":"Antipsychotic medications for cocaine dependence","author":"Amato","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006306.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T21:21:01Z","timestamp":1748812861000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006306.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,19]]},"references-count":95,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006306.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,19]]}}}